Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Bennett

Showing results (141-150 of 207) with videos related to

Pageof 21
Sort By:
JAMA|March 12, 1997
Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older personsD A Evans, L A Beckett, T S Field, et al.
Neurobiology of Aging|November 14, 2001
MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's diseaseB C Dickerson, I Goncharova, M P Sullivan, et al.
Neurology|June 4, 2008
Relation of NSAIDs to incident AD, change in cognitive function, and AD pathologyZ Arvanitakis, F Grodstein, J L Bienias, et al.
Progress in Clinical and Biological Research|January 1, 1990
CGS 19755: a novel competitive N-methyl-D-aspartate (NMDA) receptor antagonist with anticonvulsant, anxiolytic and anti-ischemic propertiesD A Bennett, J Lehmann, P S Bernard, et al.
Molecular Psychiatry|March 30, 2016
Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer's diseaseT Roostaei, A Nazeri, D Felsky, et al.
Neurology|January 26, 2005
Proneness to psychological distress and risk of Alzheimer disease in a biracial communityR S Wilson, L L Barnes, D A Bennett, et al.
The Journal of Comparative Neurology|July 28, 1999
Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's diseaseM L Gilmor, J D Erickson, H Varoqui, et al.
Progress in Clinical and Biological Research|January 1, 1990
CGS 18102A, a benzopyranopyridine anxiolytic with 5-HT1 agonist and 5-HT2 antagonist propertiesM A Sills, D A Bennett, R A Lovell, et al.
Translational Psychiatry|July 27, 2012
Cognitive reserve, presynaptic proteins and dementia in the elderlyW G Honer, A M Barr, K Sawada, et al.
The Journal of Comparative Neurology|October 24, 2000
Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's diseaseE J Mufson, S Y Ma, E J Cochran, et al.
Pageof 21

Showing results (141-150 of 207) with videos related to

Sort By:
Pageof 21
JAMA|March 12, 1997
Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older personsD A Evans, L A Beckett, T S Field, et al.
Neurobiology of Aging|November 14, 2001
MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's diseaseB C Dickerson, I Goncharova, M P Sullivan, et al.
Neurology|June 4, 2008
Relation of NSAIDs to incident AD, change in cognitive function, and AD pathologyZ Arvanitakis, F Grodstein, J L Bienias, et al.
Progress in Clinical and Biological Research|January 1, 1990
CGS 19755: a novel competitive N-methyl-D-aspartate (NMDA) receptor antagonist with anticonvulsant, anxiolytic and anti-ischemic propertiesD A Bennett, J Lehmann, P S Bernard, et al.
Molecular Psychiatry|March 30, 2016
Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer's diseaseT Roostaei, A Nazeri, D Felsky, et al.
Neurology|January 26, 2005
Proneness to psychological distress and risk of Alzheimer disease in a biracial communityR S Wilson, L L Barnes, D A Bennett, et al.
The Journal of Comparative Neurology|July 28, 1999
Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's diseaseM L Gilmor, J D Erickson, H Varoqui, et al.
Progress in Clinical and Biological Research|January 1, 1990
CGS 18102A, a benzopyranopyridine anxiolytic with 5-HT1 agonist and 5-HT2 antagonist propertiesM A Sills, D A Bennett, R A Lovell, et al.
Translational Psychiatry|July 27, 2012
Cognitive reserve, presynaptic proteins and dementia in the elderlyW G Honer, A M Barr, K Sawada, et al.
The Journal of Comparative Neurology|October 24, 2000
Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's diseaseE J Mufson, S Y Ma, E J Cochran, et al.
Pageof 21